US Stock MarketDetailed Quotes

BMEZ Blackrock Health Sciences Trust II

Watchlist

15.140
+0.120+0.80%

Close Nov 21 16:00 ET

1.57BMarket Cap-94625P/E (TTM)

Blackrock Health Sciences Trust II Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q2)Jun 30, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q2)Jun 30, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q2)Jun 30, 2021

Assets

Cash cash equivalents and federal funds sold

-56.49%16.14K

1,165.87%457.17K

-69.79%37.1K

-76.83%36.12K

-90.03%122.81K

-87.67%155.88K

-65.91%1.23M

-Cash and cash equivalents

-87.12%141

915.65%1.17K

-98.74%1.1K

-99.90%115

12,126.76%86.81K

11,828.66%119.88K

-99.66%710

-Restricted cash and investments

-55.56%16K

1,166.67%456K

0.00%36K

-97.08%36K

-97.15%36K

-63.80%1.23M

Receivables

-86.94%2.33M

46.84%1.48M

1,349.83%17.87M

-34.01%1.01M

-75.69%1.23M

18.44%1.53M

-62.01%5.07M

Prepaid assets

--20.5K

--16.16K

----

--0

139.26%48.37K

----

-Available for sale securities

--105.23M

----

Derivative assets

----

-71.21%1.43M

--963.12K

--4.96M

----

Deferred costs

--0

Total assets

-10.77%1.92B

-6.32%1.95B

0.12%2.15B

-30.89%2.09B

-38.18%2.15B

-14.84%3.02B

29.19%3.48B

Liabilities

Payables

-84.55%5.74M

-70.32%2.61M

527.39%37.16M

8.51%8.79M

-29.42%5.92M

-62.61%8.1M

49.32%8.39M

-Accounts payable

-92.56%2.27M

----

882.03%30.54M

-37.23%2.9M

-5.26%3.11M

-74.39%4.62M

36.25%3.28M

-Other payable

-47.55%3.47M

-55.69%2.61M

135.24%6.62M

69.30%5.89M

-44.94%2.81M

-3.77%3.48M

59.13%5.11M

Long term debt and capital lease obligation

--18.9K

206.23%291.88K

----

--95.31K

-95.52%69.8K

----

--1.56M

Derivative product liabilities

-11.44%17.85M

69.94%31.43M

2.23%20.15M

-20.09%18.5M

-46.54%19.71M

-53.47%23.15M

-4.07%36.88M

Other liabilities

-25.06%29.18M

572.17%12.3M

467.74%38.94M

-62.96%1.83M

9.82%6.86M

-48.42%4.94M

230.49%6.25M

Total liabilities

-45.11%52.89M

58.83%46.7M

193.66%96.35M

-19.19%29.4M

-38.98%32.81M

-55.43%36.38M

16.13%53.77M

Shareholders'equity

Share capital

-9.35%1.95B

-10.41%1.95B

-4.08%2.15B

-3.36%2.18B

-0.42%2.24B

0.00%2.25B

-common stock

-9.35%1.95B

-10.41%1.95B

-4.08%2.15B

-3.36%2.18B

-0.42%2.24B

0.00%2.25B

Retained earnings

13.38%-81.07M

63.99%-43.69M

24.71%-93.6M

-116.65%-121.32M

-110.58%-124.32M

-39.76%728.49M

197.03%1.17B

Total stockholders'equity

-9.16%1.87B

-7.25%1.91B

-2.88%2.06B

-31.04%2.06B

-38.17%2.12B

-13.88%2.98B

29.42%3.43B

Total equity

-9.16%1.87B

-7.25%1.91B

-2.88%2.06B

-31.04%2.06B

-38.17%2.12B

-13.88%2.98B

29.42%3.43B

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q2)Jun 30, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q2)Jun 30, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q2)Jun 30, 2021
Assets
Cash cash equivalents and federal funds sold	-56.49%16.14K	1,165.87%457.17K	1,165.87%457.17K	-69.79%37.1K	-76.83%36.12K	-76.83%36.12K	-90.03%122.81K	-87.67%155.88K	-87.67%155.88K	-65.91%1.23M
-Cash and cash equivalents	-87.12%141	915.65%1.17K	915.65%1.17K	-98.74%1.1K	-99.90%115	-99.90%115	12,126.76%86.81K	11,828.66%119.88K	11,828.66%119.88K	-99.66%710
-Restricted cash and investments	-55.56%16K	1,166.67%456K	1,166.67%456K	0.00%36K	0.00%36K	0.00%36K	-97.08%36K	-97.15%36K	-97.15%36K	-63.80%1.23M
Receivables	-86.94%2.33M	46.84%1.48M	46.84%1.48M	1,349.83%17.87M	-34.01%1.01M	-34.01%1.01M	-75.69%1.23M	18.44%1.53M	18.44%1.53M	-62.01%5.07M
Prepaid assets	--20.5K	--16.16K	--16.16K	----	----	----	--0	139.26%48.37K	139.26%48.37K	----
-Available for sale securities	--105.23M	----	----	----	----	----	----	----	----	----
Derivative assets	----	-71.21%1.43M	-71.21%1.43M	--963.12K	--4.96M	--4.96M	----	----	----	----
Deferred costs	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total assets	-10.77%1.92B	-6.32%1.95B	-6.32%1.95B	0.12%2.15B	-30.89%2.09B	-30.89%2.09B	-38.18%2.15B	-14.84%3.02B	-14.84%3.02B	29.19%3.48B
Liabilities
Payables	-84.55%5.74M	-70.32%2.61M	-70.32%2.61M	527.39%37.16M	8.51%8.79M	8.51%8.79M	-29.42%5.92M	-62.61%8.1M	-62.61%8.1M	49.32%8.39M
-Accounts payable	-92.56%2.27M	----	----	882.03%30.54M	-37.23%2.9M	-37.23%2.9M	-5.26%3.11M	-74.39%4.62M	-74.39%4.62M	36.25%3.28M
-Other payable	-47.55%3.47M	-55.69%2.61M	-55.69%2.61M	135.24%6.62M	69.30%5.89M	69.30%5.89M	-44.94%2.81M	-3.77%3.48M	-3.77%3.48M	59.13%5.11M
Long term debt and capital lease obligation	--18.9K	206.23%291.88K	206.23%291.88K	----	--95.31K	--95.31K	-95.52%69.8K	----	----	--1.56M
Derivative product liabilities	-11.44%17.85M	69.94%31.43M	69.94%31.43M	2.23%20.15M	-20.09%18.5M	-20.09%18.5M	-46.54%19.71M	-53.47%23.15M	-53.47%23.15M	-4.07%36.88M
Other liabilities	-25.06%29.18M	572.17%12.3M	572.17%12.3M	467.74%38.94M	-62.96%1.83M	-62.96%1.83M	9.82%6.86M	-48.42%4.94M	-48.42%4.94M	230.49%6.25M
Total liabilities	-45.11%52.89M	58.83%46.7M	58.83%46.7M	193.66%96.35M	-19.19%29.4M	-19.19%29.4M	-38.98%32.81M	-55.43%36.38M	-55.43%36.38M	16.13%53.77M
Shareholders'equity
Share capital	-9.35%1.95B	-10.41%1.95B	-10.41%1.95B	-4.08%2.15B	-3.36%2.18B	-3.36%2.18B	-0.42%2.24B	0.00%2.25B	0.00%2.25B	0.00%2.25B
-common stock	-9.35%1.95B	-10.41%1.95B	-10.41%1.95B	-4.08%2.15B	-3.36%2.18B	-3.36%2.18B	-0.42%2.24B	0.00%2.25B	0.00%2.25B	0.00%2.25B
Retained earnings	13.38%-81.07M	63.99%-43.69M	63.99%-43.69M	24.71%-93.6M	-116.65%-121.32M	-116.65%-121.32M	-110.58%-124.32M	-39.76%728.49M	-39.76%728.49M	197.03%1.17B
Total stockholders'equity	-9.16%1.87B	-7.25%1.91B	-7.25%1.91B	-2.88%2.06B	-31.04%2.06B	-31.04%2.06B	-38.17%2.12B	-13.88%2.98B	-13.88%2.98B	29.42%3.43B
Total equity	-9.16%1.87B	-7.25%1.91B	-7.25%1.91B	-2.88%2.06B	-31.04%2.06B	-31.04%2.06B	-38.17%2.12B	-13.88%2.98B	-13.88%2.98B	29.42%3.43B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	Unqualified Opinion	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data